Richardson Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Richardson Capital Management's ABBV Position: Q2 2026 in Review
Richardson Capital Management reduced its AbbVie (ABBV) stake by 15% in Q2 2026, selling an estimated $1.29K and leaving 35 shares worth $8.81K. The position accounts for ﹤0.01% of the portfolio, ranked #197.
Richardson Capital Management first reported a position in ABBV in Q1 2025 and has held it in 4 quarters since. The position peaked at $8.92K in Q1 2026. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Richardson Capital Management held 35 shares of AbbVie worth $8.81K as of Q2 2026.
- Richardson Capital Management sold 6 AbbVie shares in Q2 2026, an estimated $1.29K.
- AbbVie made up ﹤0.01% of Richardson Capital Management's portfolio in Q2 2026, its #197 holding.
- Richardson Capital Management first reported a position in AbbVie in Q1 2025 and has held it in 4 quarters since.
- Richardson Capital Management's AbbVie position peaked at $8.92K in Q1 2026.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Richardson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.